Schrum Private Wealth Management LLC Lowers Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Schrum Private Wealth Management LLC trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 20.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,169 shares of the medical equipment provider’s stock after selling 569 shares during the quarter. Schrum Private Wealth Management LLC’s holdings in Intuitive Surgical were worth $1,132,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Howard Capital Management Group LLC raised its position in shares of Intuitive Surgical by 4.5% in the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock worth $1,044,000 after purchasing an additional 92 shares during the last quarter. Impax Asset Management Group plc raised its holdings in Intuitive Surgical by 43.9% in the third quarter. Impax Asset Management Group plc now owns 5,167 shares of the medical equipment provider’s stock worth $2,538,000 after buying an additional 1,577 shares during the last quarter. Crestwood Advisors Group LLC grew its holdings in shares of Intuitive Surgical by 3.2% during the third quarter. Crestwood Advisors Group LLC now owns 4,432 shares of the medical equipment provider’s stock valued at $2,177,000 after buying an additional 139 shares during the last quarter. Avidian Wealth Enterprises LLC raised its holdings in Intuitive Surgical by 7.0% in the 3rd quarter. Avidian Wealth Enterprises LLC now owns 656 shares of the medical equipment provider’s stock worth $322,000 after acquiring an additional 43 shares during the last quarter. Finally, Catalina Capital Group LLC boosted its stake in Intuitive Surgical by 6.6% during the 3rd quarter. Catalina Capital Group LLC now owns 2,668 shares of the medical equipment provider’s stock valued at $1,311,000 after purchasing an additional 166 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $568.02 on Thursday. The company has a market cap of $202.32 billion, a P/E ratio of 88.61, a P/E/G ratio of 5.85 and a beta of 1.43. The business’s 50 day moving average price is $571.70 and its 200-day moving average price is $530.90. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Mark Brosius sold 492 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total value of $282,299.76. Following the sale, the senior vice president now directly owns 4,056 shares in the company, valued at approximately $2,327,251.68. This represents a 10.82 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Fredrik Widman sold 810 shares of the firm’s stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the completion of the transaction, the vice president now directly owns 473 shares in the company, valued at $271,397.94. This represents a 63.13 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 12,598 shares of company stock worth $7,223,467 over the last quarter. Insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the company. Wells Fargo & Company boosted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. BTIG Research increased their price target on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Jefferies Financial Group upped their price objective on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Citigroup raised their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Finally, Barclays upped their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.